AIT Bioscience competitors
AIT Bioscience Competitors include Cmed, Hanger, Advanced Oncotherapy and Affymetrix.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  AIT Bioscience AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials. |  Cmed Cmed is a full service, global CRO specialized in the design and delivery of innovative and traditional early phase patient clinical trials. |  Hanger Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service. |  Advanced Oncotherapy Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers. |  Affymetrix Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level. |
Founding Date | Founding Date 2009 | Founding Date 1999 | Founding Date 1861 | Founding Date 1994 | Founding Date 1994 |
Type | Type Private | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Indianapolis, US HQ | Locations West Sussex, GB HQ Sânnicolau Mare, RO San Bruno, US Durham, US Cambridge, US | Locations Austin, US HQ | Locations London, GB HQ Rolle, CH Syracuse, US | |
Employees | Employees 582% increase | Employees 2904% increase | Employees 4,600 | Employees 51 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 705.5 m | Valuation ($) 28.9 m | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 2.9 k | Twitter followers 821 | Twitter followers 2 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £2.4m (FY, 2017) | Revenue (est.) $1b (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $359.8m (FY, 2015) |
Cost of goods | Cost of goods N/A | Cost of goods £503k (FY, 2017) | Cost of goods N/A | Cost of goods N/A | Cost of goods $110.8m (FY, 2015) |
Gross profit | Gross profit N/A | Gross profit £1.9m (FY, 2017) | Gross profit N/A | Gross profit N/A | Gross profit $249m (FY, 2015) |
Net income | Net income N/A | Net income £319k (FY, 2017) | Net income ($858k) (FY, 2018) | Net income (£13.7m) (FY, 2017) | Net income $10.1m (FY, 2015) |
Funding | |||||
Latest funding round | Latest funding round $ 500k (over 4 years ago) | Latest funding round $ 7.5m (over 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Cmed
HQ
West Sussex, GB
Employees
290↑ 4% increase
Cmed is a full service, global CRO specialized in the design and delivery of innovative and traditional early phase patient clinical trials.
View companyHanger
HQ
Austin, US
Employees
4,600
Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.
View companyAdvanced Oncotherapy
HQ
London, GB
Employees
51
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
View companyAffymetrix
HQ
Santa Clara, US
Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.
View company